首页> 外文期刊>Molecular pharmaceutics >Effect of surface functionality of silica nanoparticles on cellular uptake and cytotoxicity
【24h】

Effect of surface functionality of silica nanoparticles on cellular uptake and cytotoxicity

机译:二氧化硅纳米颗粒表面功能对细胞摄取和细胞毒性的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Mesoporous silica nanoparticles (MCM-41) with different surface chemistry were used as carrier system to study its influence on drug delivery and anticancer activity of curcumin (CUR). CUR was encapsulated in pristine MCM-41 (hydrophilic and negatively charged), amino functionalized MCM-41 (MCM-41-NH2 which is hydrophilic and positively charged), and methyl functionalized MCM-41 (MCM-41-CH3 which is hydrophobic and negatively charged) and evaluated for in vitro release and cell cytotoxicity in human squamous cell carcinoma cell line (SCC25). Various techniques were employed to evaluate the performance of these materials on cellular uptake and anticancer activity in the SCC25 cell line. Both positively and negatively charged surfaces demonstrated enhanced drug release and anticancer activity compared to pure CUR. Positively charged nanoparticles showed higher cell uptake compared to negatively charged nanoparticles owing to its electrostatic interaction with cells. However, hydrophobic surface modified nanoparticles (MCM-41-CH3) showed no improvement in drug release and anticancer activity due to its poor wetting effect. Cell cycle analysis and cell apoptosis studies revealed different pathway mechanisms followed by the positively and negatively charged nanoparticles but exhibiting similar anticancer activity in SCC25 cells.
机译:以具有不同表面化学性质的介孔二氧化硅纳米粒子(MCM-41)为载体体系,研究了其对姜黄素(CUR)的给药和抗癌活性的影响。 CUR封装在原始的MCM-41(亲水且带负电荷),氨基官能化的MCM-41(亲水且带正电荷的MCM-41-NH2)和甲基官能化的MCM-41(疏水且带电荷的MCM-41-CH3)中负电荷)并评估其在人鳞状细胞癌细胞系(SCC25)中的体外释放和细胞毒性。采用了各种技术来评估这些材料在SCC25细胞系中对细胞摄取和抗癌活性的性能。与纯CUR相比,带正电和带负电的表面均显示出增强的药物释放和抗癌活性。与带负电的纳米粒子相比,带正电的纳米粒子由于与细胞发生静电相互作用,因此具有更高的细胞摄取能力。然而,疏水性表面改性的纳米颗粒(MCM-41-CH3)由于其较差的润湿效果而未显示出药物释放和抗癌活性的改善。细胞周期分析和细胞凋亡研究表明,不同的途径机制依次为带正电荷和带负电荷的纳米颗粒,但在SCC25细胞中表现出相似的抗癌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号